Partnership for Research & Dissemination of Evidence-Based Medicine in Autism

描述(由申请人提供)：我们建议利用创新的方法来开发现有循证医学(EBIV！)的内容定制。针对自闭症和自闭症谱系障碍(ASD)的产品，并通过社交媒体和其他以技术为基础的电子渠道评估和传播我们的产品，向尚未明确目标或接触到的关键利益相关者群体传播我们的产品。我们目前正在为AHRQ的iAdapt计划(R18 HS019271：PI，Mark Harris)资助的一个项目生成定制的ASD比较有效性研究信息。对于这一合作伙伴关系，我们的跨学科团队由南加州大学电影艺术学院的教师领导，建议扩展这项工作，并与主要合作伙伴一起开发高效、统一和可持续的高通量传播基础设施，以提高定制的循证医学产品在卫生和教育系统、临床实践、照顾者和家庭层面的渗透率和使用。我们应用创新的方法来开发戏剧性和激动人心的视频、网络视频和互动媒体产品。我们与兰德公司AHRQ资助的南加州循证实践中心的合作关系将确保我们的产品准确反映现有ASD循证医学产品的内容，并将提高它们在决策中的使用、价值和影响。我们将通过基于技术的渠道和社交媒体渠道-包括互动网页-Facebook页面，采用新的高通量传播方法。Twitter feed和一个品牌YouTube频道--使我们的目标利益相关者受众能够快速、轻松地下载：(1)全国自闭症互动网络中的15,000名ASD儿童的家长；(2)洛杉矶联合学区的3,716名主要是非洲裔和西班牙裔教师；(3)盖辛格健康体系中260万农村、低收入、医疗服务不足的成员和1,351名提供者；以及(4)加州最大的非营利性医疗计划中的320万种族多元化成员和8,400名提供者。凯撒长寿北加州。我们的基础设施将促进将ASD循证医学证据整合到医疗保健和教育系统的实践和决策中。

DESCRIPTION (provided by the applicant): We propose to utilize innovative methods to develop customizations of content of existing evidence-based medicine (EBIV!) products for autism and autism spectrum disorders (ASD), and to evaluate and disseminate our products through social media and other electronic, technology-based channels to critical stakeholder populations not already specifically targeted or reached. We currently are generating customized ASD comparative effectiveness research information for a project funded by AHRQ's iADAPT program (R18 HS019271: PI, Mark Harris). For this partnership, our trans-disciplinary team led by faculty at the University of Southern California's School of Cinematic Arts proposes to extend this work and develop a highly effective, unified and sustainable high-throughput dissemination infrastructure with key partners to improve the penetration and use of customized EBM products at health and educational systems, clinical practice, caregiver and family levels. We apply innovative approaches to develop dramatic and emotionally engaging videos, webisodes and interactive media products. Our partnership with the AHRQ-funded Southern California Evidence-Based Practice Center at the RAND Corporation will ensure that our products accurately reflects the content of existing ASD EBM products and will enhance their use, value and impact in decision-making. We will employ novel methods of high-throughput dissemination through technology-based and social media channels - including an interactive webpage, Facebook page. Twitter feed and a branded YouTube channel - to enable rapid and easy downloading by our targeted stakeholder audiences of over 5 million: (1) 15,000 parents of ASD children in the nationwide Interactive Autism Network; (2) 3,716 predominately African American and Hispanic teachers in the Los Angeles Unified School District; (3) 2.6 million rural, low income, medically underserved members and 1,351 providers in Geisinger Health System; and (4) 3.2 million ethnically diverse members and 8,400 providers in California's largest nonprofit health plan. Kaiser Permanente Northern California. Our infrastructure will facilitate integration of ASD EBM evidence into practice and decision-making in the health care and education systems.